Theralase Technologies Inc. (TLTFF)
Develops light-activated cancer drugs and laser therapy devices for treating tumors and pain.
$0.19-0.03%Healthcare
StockGlow Score
Leaning Bullish
BearishBullish
1 year ago+28.6%
The outlook
TLTFF trades at $0.185, sitting above both its 50- and 200-day moving averages in a modest uptrend. The stock sits roughly 40% of the way through its 52-week range, closer to its lows than highs. Overall sentiment leans bullish, though analyst coverage appears limited.
What’s behind the score
Price trendAbove its 50- & 200-day averages
52-week range40% of the way from its 52-week low to high
Market cap
$54.7M
52-wk high
$0.31
52-wk low
$0.10
50-day avg
$0.18
200-day avg
$0.18
Trailing P/E
—